Cargando…
microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus
The ATP-gated ionotropic P2X7 receptor (P2X7R) modulates glial activation, cytokine production and neurotransmitter release following brain injury. Levels of the P2X7R are increased in experimental and human epilepsy but the mechanisms controlling P2X7R expression remain poorly understood. Here we i...
Autores principales: | Jimenez-Mateos, Eva M., Arribas-Blazquez, Marina, Sanz-Rodriguez, Amaya, Concannon, Caoimhin, Olivos-Ore, Luis A., Reschke, Cristina R., Mooney, Claire M., Mooney, Catherine, Lugara, Eleonora, Morgan, James, Langa, Elena, Jimenez-Pacheco, Alba, Silva, Luiz Fernando Almeida, Mesuret, Guillaume, Boison, Detlev, Miras-Portugal, M. Teresa, Letavic, Michael, Artalejo, Antonio R., Bhattacharya, Anindya, Diaz-Hernandez, Miguel, Henshall, David C., Engel, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668358/ https://www.ncbi.nlm.nih.gov/pubmed/26631939 http://dx.doi.org/10.1038/srep17486 |
Ejemplares similares
-
Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation
por: Sebastián-Serrano, Álvaro, et al.
Publicado: (2016) -
Overexpression of P2X3 and P2X7 Receptors and TRPV1 Channels in Adrenomedullary Chromaffin Cells in a Rat Model of Neuropathic Pain
por: Arribas-Blázquez, Marina, et al.
Publicado: (2019) -
MicroRNA-22 Controls Aberrant Neurogenesis and Changes in Neuronal Morphology After Status Epilepticus
por: Beamer, Edward H., et al.
Publicado: (2018) -
Salient brain entities labelled in P2rx7-EGFP reporter mouse embryos include the septum, roof plate glial specializations and circumventricular ependymal organs
por: Ortega, Felipe, et al.
Publicado: (2021) -
Purinoceptor: a novel target for hypertension
por: Li, Xuan, et al.
Publicado: (2022)